About this trial
The objective of the study is to know the prevalence of pelvic floor dysfunctions in female badminton athletes compared to sedentary women, and the hypothesis is that the prevalence of pelvic floor dysfunctions is going to be higher in female badminton athletes.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Cases: women who practice recreational badminton and/or are federated and compete.
Controls: sedentary women and/or do not meet the recommendations of the World Health Organization (150-300 minutes of moderate-intensity aerobic physical activity or 75-150 minutes of vigorous-intensity aerobic physical activity).
Disqualifiers
Connective tissue diseases (Ehlers-Danlos syndrome, Marfan syndrome or hypermobility syndrome).
Pregnant at the time of the study.
Give birth in the last 12 months.
Not understanding Spanish language.
Trial population
Women from Comunidad de Madrid (Spain) who want to participate and fullfil the inclusion criteria. In the cases group, women from badminton clubs register at the "Federación Madrileña de Bádminton" and University clubs or not register in this federation.
Trial design
Case-control
Cross-sectional
Treatments tested in this trial
Assessment of pelvic floor dysfunctions' symptoms and sings, pelvic floor muscle strength and quality of life
Other interventionIt will be assessed the presence of urinary incontinence, anal incontinence, pelvic organ prolapse and female sexual dysfunction' symptoms by using the questionaries validated to Spanish population "International Consultation on Incontinence Questionnaire-Short Form", "Pelvic Floor Distress Inventory Short Form" and "Female Sexual Function Index"; in addition, the sign of stress urinary incontinence and pelvic organ prolapse will be assessed by using the cough stress test and Pelvic Organ Prolapse Quantification System, the pelvic floor muscle strength by using manometry, and quality of life by using SF-12 questionnaire.
Treatment groups
Trial outcomes
Primary outcomes
Urinary incontinence symptoms
International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF): total score greater than 0 is positive for urinary incontinence
Anal incontinence and pelvic organ prolapse symptoms
Pelvic Floor Distress Inventory Short Form (PFDI-20): item 3 pelvic organ prolapse symptom, item 9 solid fecal incontinence symptom, item 10 liquid fecal incontinence symptom, item 11 flatal incontinence symptom, item 13 fecal (rectal) urgency symptom. Affirmative answer is positive for the symptoms.
Female sexual dysfunction symptoms
Female Sexual Function Index (FSFI): total score less or equal to 26 points is positive for female sexual dysfunction risk
Secondary outcomes
Stress urinary incontinence sign
Cough stress test: with a comfortable sensation of a full bladder (200-400 mL), it is considered positive when a leakage of urine is visualized at the urethral meatus at the same time as coughing (between 1 and 4 repetitions). If the result is negative, the test should be repeated in a standing position (accessory test).
Pelvic organ prolapse sign
Pelvic Organ Prolapse Quantification System: the patient with empty bladder and rectum (if possible), the presence, type and stage of pelvic organ prolapse will be assessed by a gynecologist.
Pelvic floor muscle strength
Manometry: probe will be inserted, calibrated to 0 and asked to perform 3 maximum voluntary contractions of the pelvic floor muscle, 10 seconds break in between, after the verbal instruction "squeeze and lift the probe as strongly as possible". The total score will be the average of the three values. Measured in centimetres of water.
Participant's quality of life
SF-12 questionnaire: total score greater than 50 points, better quality of life
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: